Research Article

Association between Sleep Duration and Left Ventricular Hypertrophy for Patients with Type 2 Diabetes Mellitus

Table 2

Logistic multivariable regression analysis of factors of LVH.

VariablesBS.E.WaldOR95% CI

Age0.0070.0051.7060.1911.0070.997–1.017
DBP−0.0040.0060.4570.4990.9960.984–1.008
SBP−0.0030.0040.6760.4110.9970.99–1.004
BMI−0.0730.02310.1770.0010.930.889–0.972
Waist−0.030.00812.84<0.0010.970.955–0.986
Diabetes duration00.0010.4060.5241.00.999–1.002
Hb0.0080.0036.3520.0121.0081.002–1.015
ALT0.0010.0020.5690.4511.0010.998–1.005
BUN0.0450.0361.5770.2091.0460.975–1.121
Cr0.0150.00320.01<0.0011.0151.009–1.022
UA0.0010.0010.8340.3611.0010.999–1.002
HDL-c−0.6930.18913.422<0.0010.50.345–0.725
FT30.0280.0670.1740.6761.0280.902–1.173
Gender−1.5390.149107.209<0.0010.2150.16–0.287
History of HUA−0.2170.1851.3710.2420.8050.56–1.157
History of gout0.030.4830.0040.9511.030.4–2.652
Smoking0.1390.1520.840.3591.1490.854–1.547
Smoking history0.2360.1731.8670.1721.2660.903–1.777
Alcohol drinking−0.050.1560.1020.750.9510.701–1.292
History of drinking−0.0840.1480.3210.5710.920.688–1.229
Sleep duration0.0890.0395.2510.0221.0931.013–1.18

DBP, diastolic blood pressure; SBP, systolic blood pressure; BMI, body mass index; Hb, hemoglobin; ALT, alanine aminotransferase; BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid; HDL-c, high-density lipoprotein cholesterol; FT3, serum-free triiodothyronine; HUA, hyperuricemia.